Phathom Pharmaceuticals to Present New Data at ACG 2021 Annual Scientific Meeting

NEXT STORY
SCYNEXIS Pivotal Phase 3 VANISH-303 Trial Results Published in Clinical Infectious Diseases Demonstrate Significant Superiority of Ibrexafungerp Over Placebo for Treatment of Vaginal Yeast Infection
PREV STORY
Insights on the Polymerase Chain Reaction Consumables Global Market to 2027 – Growing Adoption of Technological Advancements Presents Opportunities
Subscribe to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Imagin Medical Secures New $3 Million Convertible Note Financing

author_avatar
NASDAQ Market News

Precision Therapeutics Releases Highlights from FY 2017 Business Update Call

author_avatar
NASDAQ Market News

Onconova Announces First Patient Dosed in Investigator-Initiated Phase 2 Study of Rigosertib in Recessive Dystrophic Epidermolysis Bullosa-Associated Squamous Cell Carcinoma

author_avatar
NASDAQ Market News